Stay updated on Durvalumab Combo in Resectable NSCLC Clinical Trial
Sign up to get notified when there's something new on the Durvalumab Combo in Resectable NSCLC Clinical Trial page.

Latest updates to the Durvalumab Combo in Resectable NSCLC Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedAdded revision v3.5.0 to the record history and removed revision v3.4.3.SummaryDifference0.1%

- Check17 days agoChange DetectedNew revision v3.4.3 was added to the history and revision v3.4.2 was removed.SummaryDifference0.1%

- Check24 days agoNo Change Detected
- Check46 days agoChange DetectedThe history now includes a new Revision: v3.4.2 entry, and the prior government funding notice and Revision: v3.4.1 entry were removed. These changes relate to page versioning and site notices rather than the trial data or study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check53 days agoChange DetectedAdded a site-wide notice about government funding and the page revision tag v3.4.1, replacing v3.4.0; no study data, eligibility, or results were affected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check60 days agoChange DetectedThe history page now includes a glossary toggle and displays change highlights using green for additions and red for deletions, along with an updated revision label. No core study content, results, or critical details were modified; to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check74 days agoChange DetectedThe page history now shows a new revision entry (v3.3.4) and the previous revision (v3.3.3) has been removed, reflecting a minor update to the record history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Durvalumab Combo in Resectable NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab Combo in Resectable NSCLC Clinical Trial page.